Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia

Completed

• Conditions: Chronic Heart Failure

• Registration Number: NCT00984529
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this study is to determine whether treatment with candesartan cilexetil for at least 6 months in patients with chronic heart failure improves clinical signs and symptoms of chronic heart failure.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-09
• Study First Submitted: 2009-09-24
• Study First Submitted QC: 2009-09-24
• Study First Posted: 2009-09-25
• Primary Completion: 2010-02
• Study Completion: 2010-02
• Status Verified: 2011-01
• Last Update Submitted: 2011-01-06
• Last Update Posted: 2011-01-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Patients with diagnosed chronic heart failure
• Patients treated for at least 6 months with candesartan cilexetil
• Signed Informed consent

Exclusion Criteria

• Hypersensitivity to candesartan cilexetil
• Pregnancy / lactation
• Severe hepatic impairment

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate clinical signs and symptoms of chronic heart failure (in terms of NYHA status, fluid retention and tiredness/fatigue) after at least 6 months of treatment with candesartan cilexetil	1 visit (after at least 6 months of treatment)

Secondary Outcome Measures

Name	Time	Method
To evaluate ventricular function after at least 6 months of treatment with candesartan cilexetil	1 visit (after at least 6 months of treatment)
To gain insight into usage of candesartan cilexetil in real life for chronic heart failure in Croatia	1 visit (after at least 6 months of treatment)
To evaluate patient's compliance with prescribed treatment	1 visit (after at least 6 months of treatment)

Trial Locations

Locations (2)

Research Site; 🇭🇷 Zagreb, Croatia

Reserach Site; 🇭🇷 Zabok, Croatia